Woodline Partners’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1M | Buy |
248,921
+151
| +0.1% | +$15.2K | 0.13% | 232 |
|
|
2025
Q1 | $19M | Buy |
248,770
+86,540
| +53% | +$6.6M | 0.12% | 238 |
|
|
2024
Q4 | $11.2M | Sell |
162,230
-54,149
| -25% | -$3.74M | 0.08% | 315 |
|
|
2024
Q3 | $15.8M | Buy |
216,379
+61,224
| +39% | +$4.47M | 0.13% | 220 |
|
|
2024
Q2 | $10.4M | Buy |
+155,155
| New | +$10.4M | 0.1% | 241 |
|
|
2023
Q1 | – | Sell |
-190,000
| Closed | -$3.8M | – | 703 |
|
|
2022
Q4 | $3.8M | Buy |
+190,000
| New | +$3.8M | 0.05% | 357 |
|
|
2022
Q1 | – | Sell |
-100,185
| Closed | -$2.73M | – | 769 |
|
|
2021
Q4 | $2.73M | Sell |
100,185
-113,783
| -53% | -$3.1M | 0.04% | 378 |
|
|
2021
Q3 | $5.89M | Sell |
213,968
-182,583
| -46% | -$5.03M | 0.1% | 230 |
|
|
2021
Q2 | $11.3M | Buy |
+396,551
| New | +$11.3M | 0.21% | 122 |
|